Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ABBV | JNJ | NVS | ||
| Company | Abbvie Inc | Johnson & Johnson | Novartis Ag ADR | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 215.61 | 219.04 | 143.78 | ||
| High | 217.35 | 220.11 | 144.76 | ||
| Low | 213.88 | 218.14 | 142.89 | ||
| Latest | 214.35 | 218.66 | 144.34 | ||
| Change | -0.67 | -0.91 | +1.19 | ||
| % Change | -0.31% | -0.41% | +0.83% | ||
| Volume | 8,649,700 | 10,021,500 | 1,651,500 | ||
| 20-Day Average Volume | 6,425,030 | 8,115,815 | 1,406,515 | ||
| Previous Close | 215.02 | 219.57 | 143.15 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 225.01 | 208.94 | 140.10 | ||
| 20-Day Raw Stochastic | 2.03% | 92.45% | 82.57% | ||
| 20-Day Relative Strength | 40.58 | 67.27 | 65.90 | ||
| Weighted Alpha | +19.62 | +53.26 | +47.79 | ||
| Today's Opinion | 24% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 24% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 72% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.60% since 01/09/26 | +6.98% since 01/09/26 | +1.98% since 01/09/26 | ||
| Low | 213.88 on 01/16/26 | 203.85 on 01/12/26 | 140.30 on 01/12/26 | ||
| High | 223.34 on 01/14/26 | 220.11 on 01/16/26 | 146.35 on 01/14/26 | ||
| 1-Month | |||||
| %Chg | -4.17% since 12/16/25 | +4.47% since 12/16/25 | +6.89% since 12/16/25 | ||
| Low | 213.88 on 01/16/26 | 200.91 on 01/05/26 | 134.82 on 12/19/25 | ||
| High | 237.04 on 01/07/26 | 220.11 on 01/16/26 | 146.35 on 01/14/26 | ||
| 3-Month | |||||
| %Chg | -5.52% since 10/16/25 | +13.81% since 10/16/25 | +10.38% since 10/16/25 | ||
| Low | 211.69 on 11/03/25 | 184.66 on 10/29/25 | 121.57 on 10/29/25 | ||
| High | 239.29 on 11/13/25 | 220.11 on 01/16/26 | 146.35 on 01/14/26 | ||
| 6-Month | |||||
| %Chg | +12.47% since 07/16/25 | +32.70% since 07/16/25 | +21.94% since 07/16/25 | ||
| Low | 184.63 on 07/21/25 | 162.30 on 07/17/25 | 112.34 on 08/01/25 | ||
| High | 244.81 on 10/01/25 | 220.11 on 01/16/26 | 146.35 on 01/14/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 378,839,008 | 526,816,448 | 304,907,008 | ||
| Shares Outstanding, K | 1,767,385 | 2,409,295 | 2,112,422 | ||
| Annual Sales | 56,334,000,000 | 88,821,000,000 | 51,722,000,000 | ||
| Annual Net Income | 4,278,000,000 | 14,066,000,000 | 11,941,000,000 | ||
| Last Quarter Sales | 15,776,000,000 | 23,993,000,000 | 14,358,000,000 | ||
| Last Quarter Net Income | 186,000,000 | 5,152,000,000 | 3,928,000,000 | ||
| 60-Month Beta | 0.36 | 0.34 | 0.51 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.86 on 10/31/25 | 2.80 on 10/14/25 | 2.25 on 10/28/25 | ||
| Latest Earnings Date | 02/04/26 | 01/21/26 | 02/04/26 | ||
| Most Recent Dividend | 1.730 on 01/16/26 | 1.300 on 11/25/25 | 2.596 on 03/12/25 | ||
| Next Ex-Dividends Date | 01/16/26 | 02/24/26 | 03/12/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 22.94 | 21.15 | 16.03 | ||